We chatted to IronRidge Resources' CEO Vincent Mascolo who explains why the company has become a lithium explorer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

IN BRIEF: Okyo Pharma Secures Patent For Treating Ocular Pain

Tue, 23rd Feb 2021 14:43

Okyo Pharma Ltd - London-headquartered biotechnology company - Says patent entitled 'compounds & methods for treating pain' was issued by the US Patent & Trademark Office on January 26. This patent covers a class of bovine adrenal medulla peptides linked to specific lipids that demonstrate potential for treating symptoms of neuropathic pain, ocular pain, ocular inflammation and/or dry eye disease.

"The publication of this patent on our bovine adrenal medulla-lipidated analogues provides key intelectual property protection crucial for bringing forward a candidate from this class into the clinic," said Chief Executive Gary Jacob.

Current stock price: 9.43 pence

Year-to-date change: up 26%

By Evelina Grecenko; evelinagrecenko@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

Related Shares

More News

IN BRIEF: Okyo Pharma Secures Patent For Treating Ocular Pain

IN BRIEF: Okyo Pharma Secures Patent For Treating Ocular Pain

23 Feb 21 14:43

IN BRIEF: OKYO Pharma Files Patent Application For Use Of Chemerin

IN BRIEF: OKYO Pharma Files Patent Application For Use Of Chemerin

19 Jan 21 17:35

UK EXECUTIVE CHANGE SUMMARY: Premier Oil And DP Poland Board Changes

UK EXECUTIVE CHANGE SUMMARY: Premier Oil And DP Poland Board Changes

7 Jan 21 16:02

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

18 Sep 20 15:45

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.